Argent Trust Co’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
DAM
F
Argent Trust Co's NVO Position: Q1 2026 in Review
Argent Trust Co increased its Novo Nordisk (NVO) stake by 30% in Q1 2026, buying an estimated $150K and bringing the position to 13,828 shares worth $508K. The position accounts for 0.02% of the portfolio, ranked #467.
Argent Trust Co first reported a position in NVO in Q4 2020 and has held it in 22 quarters since. The position peaked at $1.28M in Q2 2024. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.
- Argent Trust Co held 13,828 shares of Novo Nordisk worth $508K as of Q1 2026.
- Argent Trust Co bought 3,171 Novo Nordisk shares in Q1 2026, an estimated $150K.
- Novo Nordisk made up 0.02% of Argent Trust Co's portfolio in Q1 2026, its #467 holding.
- Argent Trust Co first reported a position in Novo Nordisk in Q4 2020 and has held it in 22 quarters since.
- Argent Trust Co's Novo Nordisk position peaked at $1.28M in Q2 2024.
- 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.
Based on Argent Trust Co's 13F filing for Q1 2026, filed 13 May 2026.